WEBVTT - Targeting the Toughest Diseases (Sponsored Content)

0:00:00.120 --> 0:00:03.640
<v Speaker 1>I'm Edward Adams of Bloomberg Media Studios. Since you're a

0:00:03.640 --> 0:00:07.040
<v Speaker 1>subscriber to Bloomberg BusinessWeek, we thought you'd be interested in

0:00:07.080 --> 0:00:12.080
<v Speaker 1>a six episode sponsored content podcast called Targeting the Toughest Diseases.

0:00:13.000 --> 0:00:15.720
<v Speaker 1>It shows how the battle against some of humanity's most

0:00:15.800 --> 0:00:20.800
<v Speaker 1>challenging diseases is happening at the intersection of business and medicine.

0:00:21.320 --> 0:00:25.720
<v Speaker 1>Here's a full episode featuring NBA great Alonzo Mourning recounting

0:00:25.760 --> 0:00:27.560
<v Speaker 1>his fight against kidney disease.

0:00:33.120 --> 0:00:37.440
<v Speaker 2>Miami Arena, March twenty ninth, nineteen ninety six. The Miami

0:00:37.479 --> 0:00:43.159
<v Speaker 2>Heat are facing the Washington Bullets all night long. Alonzo

0:00:43.240 --> 0:00:45.839
<v Speaker 2>Morning of the Heat has been guarded by a giant

0:00:45.960 --> 0:00:49.600
<v Speaker 2>of a man named George Morrissan. At seven foot seven,

0:00:49.960 --> 0:00:52.560
<v Speaker 2>Morrisson is one of the fiercest players in the league,

0:00:52.800 --> 0:00:56.840
<v Speaker 2>the tallest player in NBA history, an impenetrable wall with

0:00:56.920 --> 0:01:03.080
<v Speaker 2>a NonStop motor, but Alonzo Morning is one of the

0:01:03.080 --> 0:01:08.600
<v Speaker 2>greatest ever to step on the court. When the final

0:01:08.600 --> 0:01:11.400
<v Speaker 2>buzzer goes, the Heat have won one hundred and twelve

0:01:11.480 --> 0:01:15.800
<v Speaker 2>to ninety three, and Morning has scored an incredible fifty points.

0:01:16.240 --> 0:01:18.840
<v Speaker 2>That game was a career high for Morning. He would

0:01:18.880 --> 0:01:21.080
<v Speaker 2>go on to be a seven time All Star and

0:01:21.120 --> 0:01:24.479
<v Speaker 2>a gold medalist in the two thousand Olympics, But little

0:01:24.480 --> 0:01:27.720
<v Speaker 2>did he know his toughest opponent was yet to come.

0:01:29.240 --> 0:01:32.679
<v Speaker 2>After returning from the Olympics in Sydney, morning started into

0:01:32.720 --> 0:01:36.560
<v Speaker 2>his usual off season training, but he noticed something was wrong.

0:01:37.000 --> 0:01:42.640
<v Speaker 3>I was experiencing lethargy, edema in my legs, swelling and

0:01:42.680 --> 0:01:48.000
<v Speaker 3>my lower extremities. Extremely tired, worn out.

0:01:48.880 --> 0:01:52.320
<v Speaker 2>He thought it was jetlag, maybe the flu. He figured

0:01:52.360 --> 0:01:55.280
<v Speaker 2>he'd just take a couple days off then resume his training.

0:01:55.840 --> 0:01:59.120
<v Speaker 2>His doctor had a different idea. He suggested they run

0:01:59.160 --> 0:01:59.720
<v Speaker 2>some tests.

0:02:00.360 --> 0:02:04.000
<v Speaker 3>I answered the phone next to the bed and he said,

0:02:04.080 --> 0:02:07.000
<v Speaker 3>you know, I got your results back. He said that

0:02:07.080 --> 0:02:14.400
<v Speaker 3>you've got this rare genetic disorder called focal segmental glamary

0:02:14.480 --> 0:02:17.640
<v Speaker 3>los carosis. And I said, Doc, what is that? He said,

0:02:17.639 --> 0:02:20.040
<v Speaker 3>It's a disease that scars the filters in the kidney.

0:02:20.480 --> 0:02:25.000
<v Speaker 2>Focal segmental glamory you losclerosis or FSGS causes scar tissue

0:02:25.040 --> 0:02:27.080
<v Speaker 2>to develop on the small parts of the kidneys that

0:02:27.120 --> 0:02:28.360
<v Speaker 2>filter waste from the blood.

0:02:28.639 --> 0:02:32.480
<v Speaker 3>I asked them three questions. I said, is there a

0:02:32.520 --> 0:02:37.720
<v Speaker 3>cure for this? He said, no, I said, can I

0:02:37.720 --> 0:02:43.400
<v Speaker 3>play basketball again? He said, I don't know, And then

0:02:43.560 --> 0:02:45.480
<v Speaker 3>I said, well, am I going to die?

0:02:54.080 --> 0:02:54.240
<v Speaker 4>Hi?

0:02:54.560 --> 0:02:57.560
<v Speaker 2>I'm Jordan Gospore. I'm a member of the University of

0:02:57.600 --> 0:03:01.200
<v Speaker 2>Southern California's Center for Health Journalism. This is Targeting the

0:03:01.240 --> 0:03:05.360
<v Speaker 2>Toughest Diseases a podcast produced by Bloomberg Media Studios and

0:03:05.480 --> 0:03:09.079
<v Speaker 2>Vertex Pharmaceuticals. In this series, we look at some of

0:03:09.160 --> 0:03:13.480
<v Speaker 2>humanity's most challenging diseases and how Vertex, a Boston based

0:03:13.480 --> 0:03:17.560
<v Speaker 2>biotech company, is using innovative tools, methods, and a unique

0:03:17.560 --> 0:03:22.639
<v Speaker 2>philosophy to search for treatments and cures. Today, we're looking

0:03:22.720 --> 0:03:26.240
<v Speaker 2>at apol one mediated kidney disease, a disease caused by

0:03:26.280 --> 0:03:30.280
<v Speaker 2>a genetic abnormality, one that thirteen percent of African Americans carry.

0:03:30.880 --> 0:03:34.200
<v Speaker 2>This abnormality can cause a number of types of kidney diseases,

0:03:34.560 --> 0:03:37.880
<v Speaker 2>one of which is FSGS, the condition alonzo morning was

0:03:37.920 --> 0:03:38.520
<v Speaker 2>diagnosed with.

0:03:41.760 --> 0:03:48.600
<v Speaker 3>I thought to myself, not why me, but why right now? God?

0:03:48.760 --> 0:03:51.920
<v Speaker 3>Why am I dealing with dish right now? Of all times.

0:03:52.560 --> 0:03:55.440
<v Speaker 3>I had just come back from the Sydney, Australia Olympics

0:03:55.440 --> 0:03:57.520
<v Speaker 3>win in the gold medal. I had just come off

0:03:57.520 --> 0:04:01.360
<v Speaker 3>from an amazing basketball season where I had first team

0:04:01.400 --> 0:04:04.960
<v Speaker 3>All NBA All Star Team. The list goes on, you know,

0:04:05.120 --> 0:04:09.320
<v Speaker 3>all the accolades, and then all of a sudden, bam.

0:04:09.480 --> 0:04:10.080
<v Speaker 3>This happens.

0:04:10.600 --> 0:04:14.880
<v Speaker 2>Lots of young professional athletes view themselves as invincible. Alonso

0:04:15.000 --> 0:04:17.800
<v Speaker 2>suddenly found out he wasn't hung off the.

0:04:17.760 --> 0:04:22.680
<v Speaker 3>Phone and my face fell in my hands. I felt

0:04:22.760 --> 0:04:24.240
<v Speaker 3>like I was gonna play till I was in my

0:04:24.360 --> 0:04:27.680
<v Speaker 3>forties because I was in such great shape. Just airing

0:04:27.720 --> 0:04:30.240
<v Speaker 3>it from somebody saying hey, you got to stop playing.

0:04:31.240 --> 0:04:33.839
<v Speaker 3>It was humbling and it was deflating. Yeah, and I

0:04:34.040 --> 0:04:37.000
<v Speaker 3>just was just sitting there just trying to figure out, Okay,

0:04:37.480 --> 0:04:39.640
<v Speaker 3>how is this all going to materialize?

0:04:44.200 --> 0:04:47.680
<v Speaker 2>We can't survive without our kidneys. They played a vital role.

0:04:48.279 --> 0:04:51.080
<v Speaker 2>They help our bodies maintain just the right balance of

0:04:51.080 --> 0:04:55.800
<v Speaker 2>electrolytes like potassium, They control blood pressure, they cleaner blood,

0:04:56.320 --> 0:05:00.000
<v Speaker 2>and they even help maintain our hormone levels. Each kidney

0:05:00.200 --> 0:05:02.760
<v Speaker 2>is made up of a million or so tiny filters

0:05:02.880 --> 0:05:07.520
<v Speaker 2>called gloomerulie. They're like little coffee filters. The filtered liquid

0:05:07.560 --> 0:05:10.799
<v Speaker 2>becomes urine and the protein left behind stays in our blood.

0:05:11.000 --> 0:05:14.719
<v Speaker 2>But when the glomerulaie become damaged, those proteins start leaking

0:05:14.760 --> 0:05:18.159
<v Speaker 2>into the urine. The scary thing is it's estimated thirty

0:05:18.160 --> 0:05:20.960
<v Speaker 2>seven million adults in the United States have kidney disease,

0:05:21.279 --> 0:05:23.960
<v Speaker 2>and ninety percent of them don't even know they have it.

0:05:24.480 --> 0:05:27.320
<v Speaker 2>And in the case of apol one mediated kidney disease,

0:05:27.640 --> 0:05:32.279
<v Speaker 2>the prime causal factor is invisible. It's genetic caused by

0:05:32.400 --> 0:05:40.400
<v Speaker 2>mutations in the apoel one gene. Back in the early

0:05:40.480 --> 0:05:44.320
<v Speaker 2>nineteen nineties, doctor David Friedman, a doctor researcher and an

0:05:44.360 --> 0:05:47.560
<v Speaker 2>associate professor with Harvard Medical School who currently works with

0:05:47.680 --> 0:05:51.240
<v Speaker 2>Vertex on its clinical trials, first started to notice something unusual.

0:05:51.600 --> 0:05:55.120
<v Speaker 2>He was seeing African American families where multiple members all

0:05:55.160 --> 0:05:56.040
<v Speaker 2>had kidney disease.

0:05:56.880 --> 0:06:00.320
<v Speaker 4>When there's an important inherited component of a disay disease,

0:06:00.560 --> 0:06:02.400
<v Speaker 4>it tends to cluster in families.

0:06:03.000 --> 0:06:06.600
<v Speaker 2>Understanding there was a genetic cause was just the beginning. Next,

0:06:06.640 --> 0:06:08.480
<v Speaker 2>they had to find the exact gene.

0:06:10.800 --> 0:06:14.040
<v Speaker 4>I think a real breakthrough in our understanding came in

0:06:14.040 --> 0:06:17.320
<v Speaker 4>two thousand and eight when some teams at Johns Hopkins

0:06:17.320 --> 0:06:21.280
<v Speaker 4>and the NIH were the first to find a location

0:06:21.440 --> 0:06:25.040
<v Speaker 4>in the genome. My chromosome twenty two, where it became

0:06:25.080 --> 0:06:28.800
<v Speaker 4>apparent that there was something strong that was impacting kidney

0:06:28.800 --> 0:06:30.880
<v Speaker 4>disease in people of African ancestry.

0:06:31.200 --> 0:06:34.800
<v Speaker 2>Then in twenty ten, doctor Friedman and his colleagues identified

0:06:34.960 --> 0:06:38.320
<v Speaker 2>the specific mutations that led to this type of kidney disease.

0:06:38.800 --> 0:06:44.120
<v Speaker 4>There were two important advances in technology which really helped

0:06:44.200 --> 0:06:48.400
<v Speaker 4>us to pinpoint these two genetic variants in April one.

0:06:48.880 --> 0:06:54.200
<v Speaker 4>The first was related to tools for identifying positive selection

0:06:54.560 --> 0:06:59.800
<v Speaker 4>in the genome, and these mathematical tools helped us in

0:07:00.040 --> 0:07:02.720
<v Speaker 4>vision the genome in a slightly different way. And the

0:07:02.760 --> 0:07:09.760
<v Speaker 4>second major technological advance was a database of genetic variants

0:07:09.800 --> 0:07:14.560
<v Speaker 4>in people of widely diverse ancestries called the Thousand Genomes Project.

0:07:14.800 --> 0:07:17.640
<v Speaker 4>Up until that time, most of what we knew about

0:07:17.720 --> 0:07:23.760
<v Speaker 4>genetic variation came from people of European ancestry, and this new,

0:07:24.200 --> 0:07:28.679
<v Speaker 4>very powerful tool was a really equivalent of an encyclopedia

0:07:29.160 --> 0:07:31.560
<v Speaker 4>of genetic variation around the world.

0:07:32.160 --> 0:07:36.320
<v Speaker 2>From there, our understanding of apol one has continued to increase,

0:07:36.680 --> 0:07:40.600
<v Speaker 2>including why the risk variants in this gene only affect

0:07:40.640 --> 0:07:45.360
<v Speaker 2>people of recent African descent, including African American, LATINX and

0:07:45.440 --> 0:07:51.400
<v Speaker 2>Afro Caribbean communities. Thousands of years ago, a genetic mutation

0:07:51.560 --> 0:07:54.760
<v Speaker 2>in the apol one gene developed in Sub Saharan Africa

0:07:54.800 --> 0:07:56.280
<v Speaker 2>as a protective mechanism.

0:07:57.120 --> 0:08:00.600
<v Speaker 4>We all have a gene that encodes for or the

0:08:00.640 --> 0:08:04.800
<v Speaker 4>april one protein, but the version which causes kidney disease

0:08:05.120 --> 0:08:10.120
<v Speaker 4>contains some very slight changes in the instructions for building

0:08:10.160 --> 0:08:14.440
<v Speaker 4>that protein that turn out to make it very effective

0:08:14.840 --> 0:08:20.240
<v Speaker 4>for killing the trapanosomes that cause African sleeping sickness in humans.

0:08:20.880 --> 0:08:23.640
<v Speaker 2>Sleeping sickness is a disease spread by the bite of

0:08:23.640 --> 0:08:26.640
<v Speaker 2>an infected fly, and it can cause death within a

0:08:26.680 --> 0:08:29.920
<v Speaker 2>matter of weeks. But this genetic mutation stops it in

0:08:29.960 --> 0:08:30.560
<v Speaker 2>its tracks.

0:08:31.720 --> 0:08:34.640
<v Speaker 4>Because it was so effective, it spread very quickly in

0:08:34.679 --> 0:08:39.360
<v Speaker 4>the population. But it's these proteins with a slightly different

0:08:39.440 --> 0:08:42.280
<v Speaker 4>version of april one. It's very very effective for killing

0:08:42.320 --> 0:08:46.559
<v Speaker 4>trypanosomes and preventing African sleeping sickness, which is the same

0:08:46.720 --> 0:08:51.480
<v Speaker 4>version of the protein which makes the kidneys of people

0:08:51.640 --> 0:08:53.720
<v Speaker 4>sick who have this genetic variant.

0:08:54.880 --> 0:08:57.680
<v Speaker 2>We now understand that having one apo l one risk

0:08:57.800 --> 0:09:00.640
<v Speaker 2>variant could protect you from many forms of sleeping sickness,

0:09:00.679 --> 0:09:04.000
<v Speaker 2>but if you were unlucky enough to inherit too, one

0:09:04.000 --> 0:09:06.760
<v Speaker 2>from your mother and one from your father. Your chances

0:09:06.760 --> 0:09:21.880
<v Speaker 2>of getting kidney disease goes up tenfold, Doctor Fire, Doctor j.

0:09:23.120 --> 0:09:25.800
<v Speaker 2>Once your kidneys start to fail, there really are only

0:09:25.840 --> 0:09:29.440
<v Speaker 2>a few ways to stay alive. One is dialysis. It

0:09:29.480 --> 0:09:33.360
<v Speaker 2>replaces the function of the kidney. Doctor Janice Lee studies

0:09:33.440 --> 0:09:37.520
<v Speaker 2>kidney disorders at Emory University School of Medicine in Atlanta, Georgia.

0:09:38.040 --> 0:09:43.000
<v Speaker 5>Kidneys excrete waste products, and they get rid of excess

0:09:43.120 --> 0:09:47.920
<v Speaker 5>fluid from our bodies. So that's what the dialysis machine does.

0:09:48.679 --> 0:09:51.920
<v Speaker 2>Two needles are inserted into a patient's arm. One draws

0:09:51.960 --> 0:09:54.240
<v Speaker 2>blood out and sends it through the machine to be cleaned.

0:09:54.840 --> 0:09:57.760
<v Speaker 2>The other needle returns the clean blood back into the patient,

0:09:58.320 --> 0:10:01.760
<v Speaker 2>which is pretty much exactly the way kidney's work, except

0:10:02.000 --> 0:10:04.480
<v Speaker 2>while your kidney's work slowly. Twenty four hours a day,

0:10:04.559 --> 0:10:07.839
<v Speaker 2>seven days a week. Dialysis means sitting in a chair

0:10:08.200 --> 0:10:10.440
<v Speaker 2>plugged into a machine for two to three hours at

0:10:10.440 --> 0:10:14.200
<v Speaker 2>a time, three times a week. It works, but it's

0:10:14.240 --> 0:10:15.600
<v Speaker 2>not ideal if.

0:10:15.480 --> 0:10:19.360
<v Speaker 5>You really think about it. We go to the bathroom

0:10:19.440 --> 0:10:23.520
<v Speaker 5>excrete our urine two or three four times or more

0:10:23.600 --> 0:10:27.360
<v Speaker 5>a day. So when patients are in dialysis, they're really

0:10:27.400 --> 0:10:31.800
<v Speaker 5>getting their blood cleansed just three days a week for

0:10:31.920 --> 0:10:36.720
<v Speaker 5>a few hours, and so patients can feel washed out

0:10:36.880 --> 0:10:39.920
<v Speaker 5>when they get off of dialysis because they've had all

0:10:40.000 --> 0:10:43.959
<v Speaker 5>this fluid from two days worth of not excreting any

0:10:44.520 --> 0:10:46.360
<v Speaker 5>waste products are fluid.

0:10:47.000 --> 0:10:50.560
<v Speaker 2>There's no cure available for chronic kidney disease. The medications

0:10:50.600 --> 0:10:53.840
<v Speaker 2>currently on the market focus on making sure a person's

0:10:53.880 --> 0:10:58.720
<v Speaker 2>kidneys don't deteriorate further. The current options include medications that

0:10:58.800 --> 0:11:04.040
<v Speaker 2>suppress the immune system, diuretics, ace inhibitors or ARB medications

0:11:04.080 --> 0:11:08.160
<v Speaker 2>to control blood pressure, or lower urine protein anticoagulants to

0:11:08.240 --> 0:11:11.480
<v Speaker 2>prevent blood clots. And then there's the option Alonzo Morning

0:11:11.520 --> 0:11:15.720
<v Speaker 2>had done for his FSGS, a kidney transplant. That approach

0:11:15.800 --> 0:11:18.880
<v Speaker 2>requires you to be fortunate enough to find a suitable donor.

0:11:19.280 --> 0:11:22.400
<v Speaker 2>On average, it also only lasts ten to twelve years.

0:11:25.120 --> 0:11:28.760
<v Speaker 2>Vertex Pharmaceuticals is a company that is researching apol one

0:11:28.800 --> 0:11:32.200
<v Speaker 2>mediated kidney disease and other tough diseases where there's a

0:11:32.280 --> 0:11:35.680
<v Speaker 2>huge unmet need. They are targeting conditions where the human

0:11:35.720 --> 0:11:39.680
<v Speaker 2>biology is understood, the technology already exists, or Vertex thinks

0:11:39.679 --> 0:11:42.120
<v Speaker 2>it can develop it and where Vertex has an approach

0:11:42.240 --> 0:11:45.800
<v Speaker 2>they think maybe transformative. They have several programs in their

0:11:45.840 --> 0:11:53.320
<v Speaker 2>investigational research, including apol one mediated kidney disease. Doctor ogo

0:11:53.360 --> 0:11:56.959
<v Speaker 2>Egbunna leads clinical development for the team researching kidney disease

0:11:57.000 --> 0:11:57.640
<v Speaker 2>at Vertex.

0:11:58.200 --> 0:12:00.559
<v Speaker 6>As we speak here in the US, there probably more

0:12:00.559 --> 0:12:04.560
<v Speaker 6>than one hundred thousand people waiting for a kidney, and

0:12:04.679 --> 0:12:07.440
<v Speaker 6>not everyone is fortunate to be able to get one.

0:12:07.640 --> 0:12:09.840
<v Speaker 6>Many people will die waiting for a kidney.

0:12:10.240 --> 0:12:12.719
<v Speaker 2>The staggering number of people living with and dying from

0:12:12.800 --> 0:12:15.160
<v Speaker 2>kidney disease is one of the main reasons why doctor

0:12:15.240 --> 0:12:17.160
<v Speaker 2>ed Buna joined Vertex's efforts.

0:12:17.360 --> 0:12:20.080
<v Speaker 6>It was really heartbreaking, you know, at the beginning of

0:12:20.080 --> 0:12:23.320
<v Speaker 6>the year, I'd have a whole host of patients on

0:12:23.440 --> 0:12:26.800
<v Speaker 6>dialysis and at the end of the year, one or

0:12:26.800 --> 0:12:30.240
<v Speaker 6>two out of every three would have, you know, passed on.

0:12:30.760 --> 0:12:33.840
<v Speaker 6>That was just too depressing for me.

0:12:34.400 --> 0:12:38.000
<v Speaker 2>Why did Vertex choose to focus on a pall one

0:12:38.400 --> 0:12:40.400
<v Speaker 2>versus other types of kidney disease.

0:12:41.000 --> 0:12:46.079
<v Speaker 6>This is actually one of the most difficult kidney diseases

0:12:46.160 --> 0:12:51.600
<v Speaker 6>that have lagued a minority population and underserved population for

0:12:52.280 --> 0:12:56.800
<v Speaker 6>so long and for the longest time we have attributed

0:12:56.840 --> 0:12:59.800
<v Speaker 6>this to either a bad diet or lack of ex

0:13:00.120 --> 0:13:04.000
<v Speaker 6>size or nutrition, but we do know now that there

0:13:04.160 --> 0:13:07.480
<v Speaker 6>is a genetic basis for a lot of this disparity.

0:13:07.720 --> 0:13:11.840
<v Speaker 6>And I think in typical Vertex fashion, we go after

0:13:11.960 --> 0:13:16.000
<v Speaker 6>diseases that have a serious unmet need, and in addition

0:13:16.080 --> 0:13:20.280
<v Speaker 6>to that, we go after diseases where the underlying cause

0:13:20.640 --> 0:13:25.400
<v Speaker 6>is well understood and for which we apply the best

0:13:25.440 --> 0:13:27.080
<v Speaker 6>science available to try and address it.

0:13:27.280 --> 0:13:28.320
<v Speaker 2>What can we look forward to.

0:13:28.880 --> 0:13:31.200
<v Speaker 6>Part of the reason why I'm actually so excited about

0:13:31.320 --> 0:13:33.880
<v Speaker 6>what we're doing here at Vertex is because we have

0:13:34.080 --> 0:13:40.079
<v Speaker 6>found small molecule therapies that are investigational to the underlying

0:13:40.160 --> 0:13:43.800
<v Speaker 6>cause of what I've described as equal one mediated kidney disease.

0:13:44.160 --> 0:13:49.319
<v Speaker 6>We have evaluated these potential therapies in experimental settings and

0:13:49.600 --> 0:13:53.800
<v Speaker 6>first in human studies as well as a preliminary proof

0:13:53.800 --> 0:13:56.400
<v Speaker 6>of concept study in patients.

0:13:57.760 --> 0:14:01.120
<v Speaker 2>Developing a potential small molecule therapy is no easy feat,

0:14:01.520 --> 0:14:04.480
<v Speaker 2>doctor ed Buna, says scientists a Vertex have gone through

0:14:04.679 --> 0:14:08.840
<v Speaker 2>hundreds of thousands of candidate molecules in their kidney disease research.

0:14:09.760 --> 0:14:14.160
<v Speaker 6>Nothing good or great comes easy. Therein lies the promise

0:14:14.200 --> 0:14:16.480
<v Speaker 6>and the excitement While.

0:14:16.320 --> 0:14:19.360
<v Speaker 2>Their research continues. Doctor Egbunna says he and his team

0:14:19.400 --> 0:14:22.360
<v Speaker 2>at Vertex will do everything they can to raise awareness

0:14:22.360 --> 0:14:26.840
<v Speaker 2>for the disease. That includes educating on preventative measures like genotyping,

0:14:27.040 --> 0:14:29.920
<v Speaker 2>which can help determine whether a patient carries the apol

0:14:29.960 --> 0:14:31.040
<v Speaker 2>one genetic variant.

0:14:31.840 --> 0:14:35.600
<v Speaker 6>So, in addition to supporting the clinical community on patients

0:14:35.680 --> 0:14:38.640
<v Speaker 6>in increasing the rates of diagnosis of kidney disease, we

0:14:38.680 --> 0:14:43.360
<v Speaker 6>also want an increase in the awareness and of genotyping

0:14:43.720 --> 0:14:46.560
<v Speaker 6>so that precise diagnosis can be made so that the

0:14:46.720 --> 0:14:49.920
<v Speaker 6>right therapy can be brought to the patient. Dollons of

0:14:49.960 --> 0:14:52.760
<v Speaker 6>Money is one of those great examples of people that

0:14:53.040 --> 0:14:57.440
<v Speaker 6>went through the science, symptoms, the worries, the challenges of

0:14:57.600 --> 0:15:01.440
<v Speaker 6>n stage advanced kidney disease. I stunding and he got

0:15:01.520 --> 0:15:02.440
<v Speaker 6>back on his feet.

0:15:05.760 --> 0:15:09.320
<v Speaker 2>Alonzo Morning underwent a kidney transplant three years after his

0:15:09.360 --> 0:15:10.479
<v Speaker 2>initial diagnosis.

0:15:11.160 --> 0:15:16.400
<v Speaker 3>So the recovery process was grueling and it was extremely

0:15:16.520 --> 0:15:19.720
<v Speaker 3>painful at times, and it was difficult. But if you

0:15:19.760 --> 0:15:23.200
<v Speaker 3>think about anything in life worth having, it's very difficult

0:15:23.240 --> 0:15:25.400
<v Speaker 3>to get it. And I was trying to get my

0:15:25.480 --> 0:15:27.200
<v Speaker 3>help back in. I was trying to get back on

0:15:27.240 --> 0:15:29.800
<v Speaker 3>the court, So I was trying to get back to

0:15:29.840 --> 0:15:33.360
<v Speaker 3>some sense of normalcy, but it challenged me tremendously, and

0:15:33.920 --> 0:15:35.440
<v Speaker 3>it really truly challenged me.

0:15:36.200 --> 0:15:38.920
<v Speaker 2>Morning talks about his struggle to get and then adapt

0:15:38.960 --> 0:15:41.800
<v Speaker 2>to living with a new kidney, knowing full well that

0:15:41.880 --> 0:15:43.800
<v Speaker 2>he had a lot of advantages.

0:15:43.800 --> 0:15:47.600
<v Speaker 3>That was in optimal condition, excellent health, you know, but

0:15:48.720 --> 0:15:53.360
<v Speaker 3>that was the benefit of my recovery so fast, because

0:15:53.400 --> 0:15:56.800
<v Speaker 3>the doctors told me, like, hey, you know, if you

0:15:56.920 --> 0:16:01.560
<v Speaker 3>wasn't this high performance athlete, then you probably wouldn't have

0:16:01.560 --> 0:16:04.640
<v Speaker 3>bounced back as fast after the transplant.

0:16:04.920 --> 0:16:08.640
<v Speaker 2>And bounce back he did. Just three years after his transplant.

0:16:08.720 --> 0:16:11.280
<v Speaker 2>Alonso Morning would go on and win a championship with

0:16:11.320 --> 0:16:14.080
<v Speaker 2>the Miami Heat in two thousand and six, and today

0:16:14.360 --> 0:16:17.960
<v Speaker 2>he's partnering with Vertex as a spokesperson, using his profile

0:16:18.040 --> 0:16:20.600
<v Speaker 2>and his experience to advocate and educate.

0:16:21.280 --> 0:16:23.240
<v Speaker 3>You know. A big part of it is to try

0:16:23.240 --> 0:16:28.560
<v Speaker 3>to inspire and provide hope and encouragement for those who

0:16:28.640 --> 0:16:30.840
<v Speaker 3>are going through the same ordeal.

0:16:31.040 --> 0:16:33.640
<v Speaker 2>And Morning says he's hoping Vertex will be able to

0:16:33.640 --> 0:16:37.240
<v Speaker 2>help kidney patients by raising awareness of the disease, encouraging

0:16:37.280 --> 0:16:40.320
<v Speaker 2>people to visit their doctor and continuing to search for

0:16:40.360 --> 0:16:41.360
<v Speaker 2>a potential treatment.

0:16:41.960 --> 0:16:45.240
<v Speaker 3>So if this can happen, then all of what I've

0:16:45.280 --> 0:16:50.600
<v Speaker 3>gone through is so much more of a worthwhile because

0:16:51.240 --> 0:16:53.840
<v Speaker 3>I'm able to help save other people's lives.

0:17:04.320 --> 0:17:07.440
<v Speaker 2>This is Targeting the Toughest diseases. A podcast from Bloomberg

0:17:07.480 --> 0:17:11.200
<v Speaker 2>Media Studios and Vertex Pharmaceuticals. If you like what you hear,

0:17:11.520 --> 0:17:15.200
<v Speaker 2>subscribe and leave us a review. I'm Jordan Gospore. Thanks

0:17:15.200 --> 0:17:15.760
<v Speaker 2>for listening.